Transcript Highlights:

• indicate that an individual who is going to get the treatments has to recognize that this is not a FDA
• I went through all the FDA-approved drugs quite anxiously.
• I had horrible side effects from the FDA-approved drugs and could not tolerate them at all.
• The FDA has viewed that as a drug, taking that approach historically, and that's the reason why Texas
• Texas for standing up, as we've done in the past, to be the first state in America to challenge the FDA

Bills: HB1106, HB3284, HB541, HB713, HB1403, HB1586, HB1942, HB2070, HB2844, HB2851, HB3151, HB3749, HB3940, HB3963, HB4454, HB4466, HB4795, HB5154, HB5394, SB1357, HB1052, HB4099, HB4638, HB5147

Keywords: child abuse, neglect, gender identity, sexual orientation, child welfare, marriage, family, Texas Commission, family welfare, marriage support, stability, premarital education, child development, strong families, direct patient care, healthcare, physicians, medical services, insurance regulation, maternal health

Transcript Highlights:

• And there's a request to be regulated by the FDA.
• Um, FDA, TTB, all these agencies that regulate the alcohol industry need to be aligned on regulations
• And there's a request to be regulated by the FDA.
• request to be regulated by the FDA. request to be regulated by the FDA.
• > agencies<00:16:48.480> that FDA, TTB, all these agencies that FDA, TTB, all these agencies

Keywords: The livestream event for this meeting cut off shortly after the meeting began. This is the complete copy pulled from back ups., 958, all

Transcript Highlights:

• It authorizes podiatric physicians to perform certain non-FDA-approved stem cell therapies within the
• It requires stem cells to be sourced from FDA-registered and properly accredited facilities.
• The cellular type therapy, I guess we're doing, is not FDA approved.
• So I was just asking for Senator Masulo to just clarify that it is or it isn't FDA approved.
• And Senator Davis, no, they're not FDA-approved uses, but they are being used off-label.

Summary: The committee first heard Senate Bill 1414 by Sen. Polsky on congenital cytomegalovirus (CMV) education. The bill would require the Department of Health, working with medical experts, to create and distribute CMV educational materials to expectant and new parents or caregivers through hospitals, birth centers, and OB/GYN practices. An amendment removed a section that would have required instruction for medical professionals, and the amended bill was reported favorably as a committee substitute. The committee then took up a block of confirmations. Appointees on tabs 2 through 7 were recommended favorably in one vote, and Chavon Harris was separately confirmed as Secretary of the Agency for Health Care Administration after extensive questioning. Senators praised her leadership and experience, while others raised concerns about Medicaid redeterminations, the state’s CORE modernization project, Hope Florida, and a DCF anti-marijuana ad campaign; Harris said she would follow up on some issues and defended the agency’s work on transparency, managed care oversight, and access to care. Her confirmation was recommended favorably, with Sen. Berman noting opposition. Several health-related bills were then heard and advanced. SB 186 by Sen. Garcia expanded epilepsy training requirements for school personnel, including charter school bus drivers, and was reported favorably. SB 902 by Sen. Garcia, after amendments narrowing dental workforce provisions and allowing certain seizure rescue medication delegation to family home health aides, was reported favorably; testimony focused on medical marijuana regulation, practitioner accountability, and concerns about park and child-care proximity restrictions. SB 196 by Sen. Sharif created a uterine fibroid research database with privacy protections and was reported favorably after emotional testimony from a patient and supporters. SB 688 by Sen. Rodriguez would reestablish licensure of naturopathic doctors; it drew both support and skepticism about diagnosis and treatment boundaries, but was reported favorably. SB 1574, Maddie’s Law, would add biliary atresia screening to newborn screening and was strongly supported by parents describing a delayed diagnosis; it was reported favorably. SB 878 on clinical laboratory personnel, SB 1092 on podiatric medicine and certain cellular/tissue-based products, and SB 1032 on medical marijuana registry timelines and veteran fee waivers were also reported favorably, while SB 1032 drew debate over longer renewal/supply periods. The committee then began SB 1760 on Medicaid oversight and program transparency, with the sponsor describing the bill’s creation of a joint legislative oversight committee and a legislative actuary.

Transcript Highlights:

• Today, only one disposable vape carries full FDA authorization, and there's only a handful permitted
• The one FDA-authorized device was reviewed in full, battery included, and cleared as appropriate for
• I think there's some products that are FDA-approved. My question is, I think we're...
• The FDA-approved, I think there's some products that are FDA-approved.
• My question is, I think one of the FDA-approved products helps people wean off and helps them quit.

Keywords: 987, senate, all

Bills: HB199, HB222, HB223, HB224, HB235, HB246, HB405, HB535, HB554, HB907, SCR3, SB43, SB52, SB54, SB113, SB168, SB219, SB222, SB270, SB311, SB359

Keywords: nursing facilities, moratorium, healthcare, patient care, data collection, Medicaid, dental coverage, healthcare access, medical necessity, Louisiana Department of Health, Department of Children and Family Services, sunset law, statutory entities, regulatory authority, re-creation, termination dates, child welfare, foster care, children's rights, legal guardianship

Bills: AB102, AB108, AB117, AB213, AB220, AB221, AB251, AB259, AB331, AB336, AB375, AB379, AB409, AB475, AB476, AB550, AB575, AB594, SB466

Keywords: emergency medical services, ambulance, licensing, health district, paramedic, training requirements, outdoor education, recreation, grant program, environment, funding, special license plates, vehicle registration, custom plates, state revenue, transportation, public works, prevailing wage, custom fabrication, nonstandard materials

Transcript Highlights:

• this bill does is correct, it actually expands. the authority to include the administration of all FDA

Bills: HB 3772, HB 1656, HB 4504, HB 1896, HB 4420, HB 4421, HB 4076, HB 3708, HB 2806, HB 3540, HB 1586, HB 5459, HB 4553, HB 4535, HB 3811, HB 3749, HB 4255, HB 4051, HB 5098, HB 3554, HB 4539, HB 5274

Keywords: e-cigarettes, health and safety, regulations, directory, penalties, regulation, certification, compliance, manufacturers, FDA, nicotine, mental health, emergency detention, paramedic authority, mental illness, healthcare facility, public health, covenants not to compete, health care practitioners, physicians

Transcript Highlights:

• The FDA is not going to protect us. They haven't and they certainly won't now.
• We've looked at FDA data in the AER system, and we have found no correlation to that.
• I'm not only telling you that the FDA is telling you...
• I'm not worried about what the FDA is telling you regarding eating supplements.
• Two months later, the FDA launched its own investigation into the matter.

Keywords: 995, all

Summary: The Joint Committee on Public Health heard testimony on a wide range of bills focused on environmental health, disease prevention, and access to care. Major topics included restricting polystyrene use, creating a pancreatic cancer awareness and early-detection initiative, improving indoor air quality through a task force and new regulations, expanding access to epinephrine in public places, improving access to health care for people with long COVID, creating an OBGYN loan repayment program for underserved areas, expanding access to hygiene products, modernizing licensure for dietitians and nutritionists, updating school postural screening requirements, and restricting harmful diet pills and muscle-building supplements. Several legislators also testified in support of their own bills, including measures on menstrual product access and ingredient disclosure, and surgical smoke protections. Testimony on the polystyrene bill emphasized local municipal bans and the need to reduce plastic pollution. Pancreatic cancer advocates and patients described the disease’s low survival rate, the difficulty of early diagnosis, and the need for an awareness campaign and implementation of commission recommendations. Indoor air quality supporters from environmental justice groups, public health organizations, and residents described asthma, mold, pollution, and the need for a task force with technical expertise; some witnesses urged adding remediation professionals to the task force. On epinephrine access, family members of a man who died after a bee sting and an allergy organization stressed that anaphylaxis can be sudden and fatal and that stock epinephrine in public venues could save lives. Long COVID advocates said the condition affects hundreds of thousands of residents and called for better surveillance and access to care, with a request to include MECFS in the bills’ scope. Other testimony focused on workforce and equity issues. Supporters of the OBGYN loan repayment bill said it would help address maternal health disparities and provider shortages, especially in rural and underserved communities. Hope and Comfort described widespread hygiene insecurity and a long waiting list for basic products, urging a task force to study statewide solutions. Dietitians and nutritionists supported modernization of licensure to clarify standards for medical nutrition therapy while allowing broader wellness counseling. School nurses backed reducing mandatory postural screenings, arguing the current law is not evidence-based, is not reimbursed by MassHealth, and takes time from other student health needs. On the supplement bill, the industry trade group opposed restrictions as overbroad and burdensome, while a public health expert cited research linking weight-loss and muscle-building supplements to serious harms and urged passage. The committee also heard support for menstrual product access and surgical smoke protections, with legislators and advocates describing those bills as longstanding priorities.

Transcript Highlights:

• By the way, the FDA currently regulates human cell, tissue, and cellular tissue-based products under
• By the way, the FDA currently regulates human cell, tissue, and cellular tissue-based products under
• cellular or cellular-based tissue products only when they... ...certain non-FDA-approved cellular or
• at some point there will be an FDA approval or disapproval of these products?
• The FDA does do research on all type products.

Summary: The committee first confirmed six appointees in a single vote, then took up a series of bills, most of them reported favorably. The early debate centered on SB 208, a land-use bill by Sen. McLean that would require development fees to reflect review costs and create more objective compatibility standards for residential development denials. An amendment adding housing-related provisions, including an OPAGA study of urban development boundaries, drew extended discussion over the Everglades and local control; it was adopted, while a late-filed amendment on rural boundaries was withdrawn. The bill was then reported favorably after supporters and opponents, including Miami-Dade and housing groups, weighed in. The committee also favorably reported SB 686 on agricultural enclaves after amendments adding conservation, wildlife corridor, and Everglades-related protections, with one amendment specifically preserving stronger protections in counties covered by the Northern Everglades/Indian River Lagoon plan. Several criminal justice and public records measures also advanced. SB 436 would add resisting an officer with violence as a qualifying prior offense for battery enhancement and include certain felony battery offenses in prison release reoffender status. SB 830 would extend public-records protections to county and city administrators and related family information. SB 990 would authorize protected cell captive insurers in Florida. SB 600, on bail bonds, drew the most debate: an amendment by Sen. Rouson preserved the current treatment of charitable bail organizations’ deposits, with supporters arguing nonprofits help low-income defendants and critics saying the bill should distinguish commercial and nonprofit bonding; the amendment was adopted and the bill reported favorably. SB 914 on dry needling and SB 1434 on infill redevelopment also passed, the latter with an amendment removing a 10% markup requirement for buyback provisions. The committee then moved through a large education and health agenda. SB 1504 would let high school students who complete an insurance/personal finance elective qualify later for a customer service representative license. SB 1718 would expand educator preparation and temporary certification options. SB 7038 was a broad education package covering tuition waivers for Florida State Guard members, residency rules, consumer protections, dual enrollment, grading, and college funding; amendments clarified workforce licensure and exempted certain dental training from new licensure rules. SB 1092 on podiatric medicine added definitions and restrictions for cellular/tissue-based products. SB 1138 on qualified contractors created a pre-application review program for certain local governments, with historic-preservation carveouts. SB 186 on student health and safety required seizure-training and action plans in schools, and SB 560 on child welfare streamlined psychotropic-medication procedures for children in state care while adding youth advisory meetings and insurance-data review. SB 902, a broad Department of Health bill, addressed medical marijuana facility setbacks, practitioner discipline, autism microcredentials, marriage and family therapy licensure, a neurofibromatosis grant program, and family home health aide delegation; it passed after two amendments. Finally, SB 218 on land-use regulations limited hurricane-recovery restrictions to affected counties, SB 1002 expanded child-neglect definitions tied to parental drug abuse, SB 1474 tightened biosolids land-application rules, SB 1708 eased out-of-state veterinary licensure by endorsement, and SB 314 established a Florida regulatory framework for payment stablecoins aligned with federal law. Most measures were reported favorably by committee vote after brief testimony or no debate.

Transcript Highlights:

• We've heard that from our FDA colleagues as well.
• Our FDA colleagues are prepared to respond if the fly were to enter the United States; they could use
• That has to be approved by the FDA.
• So there are some outside entities petitioning the FDA to add Ivermectin, but it's going to take time
• Fortunately, both the EPA and the FDA have emergency use authority.

Keywords: 1184, house, all

Transcript Highlights:

• And that is a prescription medication that is required under FDA requirements.
• It's federally regulated and approved by FDA.
• And in order for a patient, Federally regulated and approved by FDA, and in order for a patient to get
• FDA has issued warnings about commingling it with other medications, but also there are dosages that
• FDA has issued warnings about commingling it with other medications, but also there are dosages that

Summary: The committee heard several health-related bills. SB 1082 would let providers or insurers in state-regulated commercial plans opt into the federal independent dispute resolution process for emergency out-of-network claims, with a late-filed amendment clarifying access to the state program in certain circumstances. The bill sponsor and emergency physicians said the measure would reduce litigation and improve payment resolution; the committee adopted the amendment and reported the bill favorably as a committee substitute. SB 1168 would centralize background screening work for the care provider clearinghouse at the Agency for Health Care Administration and update related screening rules, including sealed and expunged records for qualified entities. The sponsor said the change would speed turnaround and reduce duplication; an amendment was adopted, and the bill was reported favorably as a committee substitute. SB 1156 would move ambulatory surgical center regulation out of Chapter 395 into a standalone section of law, and it was reported favorably without amendment. SB 1480, as amended by a strike-all, would grandfather certain temporary certificate holders practicing in areas of critical need if federal designations change, allowing them to continue seeing current patients and potentially new patients in their existing area subject to board oversight. The committee heard support from health system representatives and reported the bill favorably. The final and most debated measure, SB 1756 on medical freedom, would require vaccine education materials and alternative schedules, expand school immunization exemptions to conscience-based objections, clarify limits on emergency vaccination orders, and allow pharmacists to dispense ivermectin behind the counter with written information. The sponsor and supporters framed it as parental choice and access, while physicians, public health advocates, cancer advocates, and parents of immunocompromised children warned it would lower vaccination rates and increase disease risk. The committee adopted a liability-related amendment, rejected a substitute amendment that would have required consultation for exemptions, and continued hearing public testimony opposing the bill; the transcript ends before final action on SB 1756.

Transcript Highlights:

• We don't even have, um, um, um, FDA or what is that inspection, USDA inspection at this point.
• We don't even have, um, um, um, FDA or what is that inspection, USDA inspection at this point.
• We don't even have, um, um, um, FDA or what is that inspection, USDA inspection at this point.
• We don't even have, um, um, um, FDA or what is that inspection, USDA inspection at this point.
• We don't even have, um, um, um, FDA or what is that inspection, USDA inspection at this point.

Keywords: 912, senate, all

Summary: The committee heard testimony on HB 345, which would establish ʻōpae ʻula as the state shrimp. The Department of Land and Natural Resources and Kua Ulu Aumo testified in strong support, saying the designation could help protect endemic shrimp in anchialine pools and increase public education and awareness. In response to questions, DLNR said it would use existing education programs, press releases, and partnerships for statewide outreach and was not seeking a separate appropriation for that purpose. Members then took up SCR 132 and SR 111, which encourage adoption of recommendations from the UN Global Plastics Treaty and the Rapa Nui Summit Declaration on climate justice and sustainable development. Greenpeace Hawaii supported the measures, arguing that plastic production is tied to fossil fuel interests and that microplastics pose serious health and environmental risks. The committee later adopted the measures with amendments, including a change from “waste hierarchy” to “zero waste hierarchy” and technical edits. The final measures, SCR 157 and SR 127, urged the state to adopt and implement the UN Convention on the Law of the Sea agreement on biodiversity beyond national jurisdiction. DLNR testified that it had only just reviewed the resolution but stood on its written testimony. The committee passed SCR 157 and SR 127 as is. The meeting also included a separate hearing on SCR 89 and SR 72, which would create a University of Hawaiʻi Community College pathway for meat processing. The Department of Agriculture, Hawaii Farm Bureau, and Hawaii Cattlemen’s Council supported the idea, citing workforce needs and local protein supply, while several members raised concerns about whether a formal educational pathway or degree requirement might unnecessarily limit entry into the field; discussion focused on whether the proposal should be more vocational and whether there is enough data on workforce demand. No final vote on those measures was shown in the transcript excerpt.

Transcript Highlights:

• With regards to the FDA, the comment was made that somehow we're decreasing funding to the FDA.
• With regards to<02:57:09.760> the<02:57:10.000> FDA, to the FDA, to the FDA, the<02:57:
• We talked about FDA.
• We talked about FDA.
• We talked about FDA.

Keywords: U.S. House of Representatives Floor Proceedings on Thursday, June 4, 2026, 1012, house, all

Transcript Highlights:

• the Federal Vaccine Adverse events Reporting System has been in use for over 2 decades, the CDC and FDA
• However, the FDA shockingly, FDA has not approved new UV blocking filters since 1996 due to the lengthy
• successfully completed phase one of the clinical trial but have not yet approved for general use by the FDA
• to use Investigative sun products if the patient's physician recommends it and determines all other FDA
• Uh, the FDA approval, uh, process is cumbersome in part because it classifies sunscreens typically as

Transcript Highlights:

• But the FDA actually came out with a recent study showing that flavored non-tobacco nicotine-based products
• But the FDA actually came out with a recent study showing that flavored non-tobacco nicotine-based products
• But the FDA actually came out with a recent study showing that flavored non-tobacco nicotine-based products
• But the FDA actually came out with a recent study showing that flavored non-tobacco nicotine-based products
• But the FDA actually came out with a recent study showing that flavored non-tobacco nicotine-based products

Keywords: 919, house, all

Transcript Highlights:

• I think, you know, its history, you look back in history, uh, throughout, um, the FDA and other, um,
• Almost 50 years later, in 2018, the FDA finally banned them.
• and we are pleased to be working closely with Secretary Kennedy, Secretary Rollins, and presumptive FDA
• dye number 3, for example, has been banned in cosmetics for over 30 years, and just last month, the FDA
• Companies adhere to rigorous evidence-based safety standards established by the FDA to deliver safe,

Bills: SB 25, SB 314

Keywords: nutrition, health standards, food labeling, education, dietary guidelines, medical education, food safety, school meals, child nutrition, food additives, public health

Transcript Highlights:

• The FDA simply is being unfair to these botanical products.
• The FDA simply is being unfair to these botanical products.
• <01:25:24.440> can Hawaii knows firsthand how the FDA can Hawaii knows firsthand how the FDA
• life was turned upside down by an FDA life was turned upside down by an FDA can<01:26:42.719>
• <01:26:53.960> approv turned upside down by an FDA approv turned upside down by an FDA approv

Keywords: 912, senate, all

Summary: The joint Senate hearing focused primarily on SB 1201, a wildfire measure that would create a wildfire recovery fund and allow securitization for electric utilities. Hawaiian Electric strongly supported the bill, saying it would help protect customers, property owners, insurers, and the broader economy from future catastrophic wildfire liability while improving the utility’s credit profile and lowering financing costs. Support also came from DCCA Consumer Advocacy, the Attorney General’s office on written comments, Ulupono Initiative, Clearway Energy Group, IBEW Local 1260, Par Hawaii, KIUC, the Chamber of Commerce Hawaiʻi, Plus Power, and numerous organizations and individuals. Opponents or commenters raised concerns about the liability cap, victim compensation process, and fund structure, including the Hawaiʻi Association for Justice, the Hawaiʻi Regional Council of Carpenters, and the Hawaiʻi Insurance Council; Henry Curtis of Life of the Land supported the concept of a fund but questioned the catastrophe threshold and whether the fund would be empty without a prudency finding. Much of the discussion centered on whether the proposed fund would actually help restore Hawaiian Electric to investment grade, with senators comparing the proposal to California’s wildfire fund. Hawaiian Electric said the bill was only one part of a broader process, alongside physical risk reduction and settlement finalization, and argued that without the bill the utility would not regain investment grade. Senators also questioned the proposed $1 billion fund size, the fairness of ratepayer contributions versus shareholder contributions, and whether customers should pay for consulting and administrative costs; Hawaiian Electric said its proposed amendment would remove those consulting-related charges. The company also said the fund would accrue interest and, if unused, could be returned to customers, and that there would be replenishment and supplemental contribution mechanisms if the fund were exhausted. The Attorney General’s office said it still had further amendments to discuss, and the departments had not yet resolved where the fund should reside administratively, though Hawaiian Electric said it believed DCCA was the appropriate place but was open to alternatives. KIUC requested two amendments. No vote or final committee action was taken during the hearing, and the measure remained under discussion with questions and proposed amendments still outstanding.

Transcript Highlights:

• Right to Try does not replace FDA oversight.
• It simply cuts the FDA, which undermines both patient safety and our drug development process in this
• The FDA, it's hardly a scientific body.
• So this is for drugs and gene therapies that likely will never even go through any FDA process because
• Because this particular drug or treatment, whatever it is, it is not FDA certified.

Bills: SB41, SB33, SB32, SB30

Keywords: sexual crimes, statute of limitations, criminal justice, victim rights, child abuse, individualized treatment, investigational treatment, health care, life-threatening illness, patient rights, physician recommendation, informed consent, human trafficking, sexual exploitation, child protection, prosecution, crime amendments, SB30, induced abortion, abortion reporting

Transcript Highlights:

• By the FDA, hulled hemp seeds, hemp seed protein powder, hemp seed oil will remain legal.
• I'm glad you brought up the other federal agencies because is it accurate that the FDA, the Food and
• The FDA said it.
• Because that's something we can take up with the Pharmaceutical Board or FDA. Right.
• There is a lot of medication, but all those have been approved through FDA, correct?

Bills: SB5, SB11, SB12, SB9, SB42, SB15, SB5, SB11, SB12, SCR1

Keywords: hemp regulation, consumable products, cannabinoids, occupational licenses, criminal offenses, SB 11, Texas attorney general, election crimes, election law enforcement, criminal prosecution, Election Code, Government Code Chapter 402, local prosecutors, county attorney, district attorney, grand jury, probable cause reports, state election offenses, voter fraud, election integrity

Transcript Highlights:

• uh, come up with alternative treatment strategies, and, uh, we will pass those lists on to, uh, The FDA
• Uh, and we continue to work with the USDA, FDA, and EPA, uh, to expand treatment options, uh, for neural
• I can say one thing I did not mention is that we are working closely with the FDA and EPA, as others
• You know, we moved the speed of government that has to be approved by the FDA.
• So there are some outside entities petitioning the FDA to add ivermectin. It's gonna take forever.